Granulosis rubra nasi
Granulosis Rubra Nasi is a rare familial disease of the nose, first described by Carl Freiherr von Rokitansky in 1860. It is characterized by hyperhidrosis of the nose, leading to the formation of small, dark red nodules and vesicles, and is often associated with a high degree of nasal hyperhidrosis.
Etiology
The exact cause of Granulosis Rubra Nasi is unknown. However, it is believed to be an autosomal dominant condition with variable penetrance. This means that an affected person has a 50% chance of passing the disorder on to each of their children. The condition is more common in males than in females.
Symptoms
The primary symptom of Granulosis Rubra Nasi is the presence of small, dark red nodules and vesicles on the nose. These are often accompanied by excessive sweating (hyperhidrosis) of the nose. Other symptoms may include a burning sensation, itching, and occasional bleeding from the nodules. The condition typically begins in childhood and may persist into adulthood.
Diagnosis
Diagnosis of Granulosis Rubra Nasi is primarily based on the clinical presentation of the symptoms. A dermatologist may perform a skin biopsy to confirm the diagnosis and rule out other conditions. Other diagnostic tests may include a sweat test to measure the amount of sweat production, and genetic testing to identify the presence of the autosomal dominant gene.
Treatment
There is currently no cure for Granulosis Rubra Nasi. Treatment is primarily aimed at managing the symptoms and may include the use of topical corticosteroids to reduce inflammation and itching. In severe cases, surgical removal of the affected skin may be considered.
Prognosis
The prognosis for individuals with Granulosis Rubra Nasi is generally good. While the condition can cause discomfort and cosmetic concerns, it does not typically affect overall health or lifespan. However, the persistent nature of the condition can have a significant impact on quality of life, and individuals may require ongoing treatment to manage symptoms.
See also
This article is a skin-disease stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
